Compagnie Lombard Odier S Cm A Novavax Inc Transaction History
Compagnie Lombard Odier S Cm A
- $5.66 Billion
- Q2 2024
A detailed history of Compagnie Lombard Odier S Cm A transactions in Novavax Inc stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 850 shares of NVAX stock, worth $9,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
850
Previous 2,600
67.31%
Holding current value
$9,885
Previous $12,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
83.2MCall Options Held
5.43MPut Options Held
9M-
Vanguard Group Inc Valley Forge, PA14.1MShares$164 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$138 Million0.0% of portfolio
-
Shah Capital Management9.66MShares$112 Million41.87% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$73.5 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$70.5 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $910M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...